Organizing Committee Members of Cancer Therapy 2018

Our Organizing Committee members are the pride of our conferences. These are the members who will make the event more memorable and happening. They will not just share their intellectual with us, but will also help us understand some of the most key areas of the topic they will be discussing with us through this conference.

It shall be a great honour to have such influential members on board to help us through the moments of this era.
Dr. Andrew V. Schally
Dr. Andrew V. SchallyNobel Prize in Physiology or Medicine,
University of Miami

Dr. Andrew V. Schally

Andrew V. Schally is distinguished medical research scientist of the department of veteran’s affairs, Prof. Andrew V. Schally is head of the Endocrine, Polypeptide and Cancer Institute Veterans Affairs Medical Center, Research Service (151) Miami, FL and South Florida VA Foundation for Research and Education also distinguished Leonard Miller Professor of Pathology, Professor Division of Hematology/Oncology and division of Endocrinology department of Medicine Sylvester Professor, Sylvester Comprehensive Cancer Center (SCCC) Miller School of Medicine, University of Miami, FL.

Renata Pasqualini, <strong>Ph.D.</strong>
Renata Pasqualini, Ph.D.Professor of Internal Medicine
Maralyn S. Budke Endowed Chair in
Cancer Experimental Therapeutics
Associate Director,
Translational Research Chief,
Division of Molecular Medicine

Renata Pasqualini, Ph.D.

Dr. Renata Pasqualini received her Ph.D. from the Ludwig Institute for Cancer Research and her postdoctoral training at Harvard Medical School and the Burnham Institute in La Jolla. She is an international expert in vascular biology, cancer metastasis, angiogenesis and, codeveloped in vivo phage display.

She serves as a board member, reviewer, and chair of multiple review panels for the NIH, the Department of Defense, the Department of Energy, and several American, Asian, and European Foundations. Drs. Arap and Pasqualini are married and established a long-standing collaboration as PIs of a large, joint laboratory since October 1999, first at The University of Texas, M. D. Anderson Cancer Center and now at the University of New Mexico.

Over the past two decades, these ground-breaking insights and efforts yielded 180+ peer-reviewed publications, 35 issued US patents, five new biotech start-ups, and two successful IND applications.

Narayan S. Hosmane
Narayan S. HosmaneDistinguished Research Professor and
Board of Trustees Professor
Department of Chemistry & Biochemistry
Northern Illinois University, USA

Narayan S. Hosmane

Narayan S. Hosmane was born in Gokarn, Southern India, and is a B.S. and MS graduate of Karnatak University, India. He obtained a Ph.D. in Inorganic Chemistry in 1974 from the University of Edinburgh. After postdoctoral research in U.K. and in the USA (UVa), he joined Virginia Tech and then moved to SMU in 1982, where he became Professor of Chemistry in 1989. In 1998 he moved to Northern Illinois University as a Distinguished Research and Board of Trustees Professor.

His international awards include but are not limited to the Alexander von Humboldt Foundation’s Senior U.S. Scientist Award twice; the BUSA Award for Distinguished Achievements in Boron Science; the Gauss Professorship of the Göttingen Academy of Sciences, Visiting Professor of the Chinese Academy of Sciences and Foreign Member of the Russian Academy of Natural Sciences. He has published over 325 papers in leading scientific journals and an author of five books on boron science and cancer therapies.

Dr. Abbas Amini
Dr. Abbas AminiAssistant Professor,
Australian College of ACK &
Western Sydney University.

Dr. Abbas Amini

Dr Abbas Amini is an assistant professor at the Australian College of ACK and Western Sydney University, and the member of graduate supervisory board. After obtaining PhD, he conducted research with other Australian universities, as a postdoctoral research fellow at Monash and Deakin Universities, and as a senior research fellow at the University of Melbourne.

His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group, and a recent published book in 2016. Abbas is the editor of ten reputed journals, and the committee member of 20 international conferences.

Research interest: Bionanotech.

Dr. Vladimir Lazar
Dr. Vladimir LazarChief Operating Officer
WIN Consortium.

Dr. Vladimir Lazar

Dr. Vladimir Lazar Chief Operating Officer of the WIN Consortium. He has obtained his MD (1989) at The University of Timisoara (Romania), first in class and certificate of Merit “Magna cum Laudae”. He became a specialist in Clinical Biology (DIS, 1977, University René Descartes in Paris) and obtained his PhD in molecular biology (1997) at The University René Descartes in Paris, with the highest degree and the prize of University.

Dr. Vladimir Lazar is specialized in clinical biology, molecular biology, molecular pathology and has a broad training, education and postgraduate degrees in biotechnology (first in class) and project management. He is a recognized specialist in translating research to clinical applications. He was the founder and head of Gustave Roussy’s Genomic center and Integrated Biology Platform (2002V2015) running the Agilent European reference and training center. He is author of 6 patents and author VcoVauthor of more than 100 publications.

As a COO he has built a strong expertise in project design, technology evaluation and implementation, use of genomics and biomarkers in oncology, companion test development, and biology driven clinical trials. He has also developed leadership and entrepreneurial skills through the creation of his initiatives.

Dr. Lazar Mathew
Dr. Lazar MathewAdvisor, Medical Sciences,
Engineering & Technology
Director of Defence
Research and Development Organisation

Dr. Lazar Mathew

Dr Lazar Mathew is an Indian scientist and former Director of Defence Research and Development Organisation and Institute of Nuclear Medicine & Allied Sciences. He has also been Director of Defence Bioengineering and Electromedical Laboratory. In 1994, he was honoured with the DRDO Scientist of the Year Award.

Mathew is serving as an advisor of Medical Sciences and Engineering and Technology at PSG Institute of Medical Sciences & Research, Coimbatore. He has served as the Dean of the School of Biotechnology and Chemical and Biomedical Engineering at VIT University, Vellore.

Dr. Farid Menaa
Dr. Farid MenaaInternational Consulting
Healthcare and Biosystems Expert

Dr. Farid Menaa

Dr. Farid Menaa (Bsc. BioEngineering ; Bsc. Biology and Physiology ; Msc. Genetics ; Master Gerontology/Geriatrics ; PhD Radiation Oncology/Gerontology (Paris, France, 2003) ; three international post-doctoral terms in Oncology, Dermatology, Stem cells, Hematology, Genomics ; MBA Entrepreneurship and MD candidate), is an experienced and skilled inter- and multi-disciplinary professional. During his career, Dr. Menaa followed complementary formations in Marine Biology (Caen, France), Pharmacy (Liege, Belgium), Biochemistry, Chemistry and Biophysics (California, USA), Business Development and Management (USA and Brazil).

Professor, Principal Investigator, Executive Director, Consulting Healthcare and Biosystems Expert, Companys’ Advisor and Coach, Supervisor, Editor, Editor-in-Chief, Reviewer, Event Organizer, Entrepreneur and Polyglot, Dr. Menaa earned his degrees with high distinctions from prestigious universities and institutions worldwide. Dr. Menaa has more than 10 years experiences either in the academic (mainly institutions from France, USA, Germany, Brazil) or in the industrial sectors such as Guerbet SA, SANOFI, Fluorotronics, Inc.

Dr. Stefan Glück
Dr. Stefan GlückMD PhD FRCPC
Professor of Medicine
Vice President,
Global Medical Affairs,
Early Assets Celgene
Corporation 86 Morris Avenue,
Summit, NJ 07901

Dr. Stefan Glück

Stefan Glück, MD, PhD is a Sylvester professor and medical oncologist in the department of medicine at the Miller School of Medicine of the University of Miami in Florida. Prior to this appointment, he was the clinical director of the Braman Family Breast Cancer Institute, assistant director of the Sylvester Comprehensive Cancer Center and associate chief of the Division of Hematology and Medical Oncology.

In addition to his clinical practice and research, Dr. Glück serves as a reviewer for journals such as the Journal of Clinical Oncology, European Journal of Cancer, Lancet Oncology, Lancet, Breast Cancer Research, The Oncologist, The Breast Journal, Clinical Breast Cancer and many others.

He is medical associate editor of Breast Cancer Research and Treatment and co-editor in chief of the Journal of Carcinogenesis. He has authored or co-authored more than 200 articles and has written or co-written a number of book chapters and numerous journal abstracts. He has presented more than 350 papers.

Dr Heping Yan
Dr Heping YanAssistant Professor
Department of Radiation Oncology
School of Medicine
Washington University
St. Louis, USA

Dr Heping Yan

Heping Yan earned his MS and MD degree at West China University of Medical Sciences. Currently, he is Assistant Professor in the Department of Radiation Oncology, School of Medicine, Washington University in St. Louis, USA.

Dr. Yan had over 20 years’ experiences of study on McAbs on ScFvs. Now, his research is focusing on production of antibody against varieties of molecules and its application. He is a co-author of a monography book titled Monoclonal Antibodies and Zoonosis which addressed its application in diagnosis and treatment of Zoonosis.

Currently his research interesting is on targeting of ionizing irradiation inducible neo-antigen on the surface of tumor cells for molecular imaging, drug delivery for cancer treatment. He has successfully produced such anti-Tip1, GRP78, CRT, P-selectin and TAF15 antibodies for applications. Dr. Yan is serving as a peer reviewer for journals and member of journal editor board.

Dr. Stefan Kempa
Dr. Stefan KempaGroup Leader
Berlin Institute for
Medical Systems Biology

Dr. Stefan Kempa

Stefan Kempa is group leader at the Berlin Institute for Medical Systems Biology BIMSB at the Max Delbruck Center for Molecular Medicine in Berlin, Germany. The group established gas chromatography coupled mass spectrometry (GC-MS) as well as liquid chromatography coupled mass spectrometry (LC-MS) based techniques to monitor the metabolome and the proteome.

In addition they have developed pulsed stable isotope resolved metabolomics (pSIRM) as a tool for a dynamic metabolic characterization of cellular metabolism. Using this technology they investigate cancer metabolism aiming to improve the understanding of cancer. The specific interest is to understand metabolic dependencies of cancer cells and to improve cancer treatment.

MomentEra is incredibly professional team of scientific event planners. At MomentEra we organize International congresses, events, workshops and exhibitions.

Follow Us